What are the inpatient blood pressure (BP) medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For managing blood pressure in the inpatient setting, I recommend starting with intravenous labetalol, as it is a preferred first-line treatment for various hypertensive emergencies, including malignant hypertension, hypertensive encephalopathy, and acute ischemic stroke, as indicated in the 2019 European Heart Journal study 1.

Key Considerations

  • Labetalol can be administered as a 10-20 mg IV bolus, which can be repeated or doubled every 10 minutes up to 300 mg total.
  • In hypertensive emergencies with end-organ damage, nicardipine infusion at 5 mg/hour, titrated by 2.5 mg/hour every 5-15 minutes up to 15 mg/hour, or clevidipine starting at 1-2 mg/hour and titrated every 90 seconds, are excellent alternatives, as suggested by the 2018 Circulation study 1.
  • For ongoing BP management, transition to oral medications as soon as clinically appropriate, with first-line oral options including ACE inhibitors, ARBs, calcium channel blockers, or thiazide diuretics.

Medication Selection

  • The choice of medication should be tailored to the patient's comorbidities, with ACE inhibitors or ARBs preferred in diabetes or kidney disease, and calcium channel blockers or thiazides in Black patients, as recommended by the 2018 Circulation study 1.
  • Beta-blockers like metoprolol are particularly useful in patients with coronary artery disease or heart failure.

Monitoring and Adjustments

  • Regular monitoring of blood pressure, electrolytes, and kidney function is essential during medication adjustments, as emphasized by the 2024 Annals of Internal Medicine study 1.
  • The 2024 Annals of Internal Medicine study 1 highlights the importance of systematic identification of guidelines on elevated BP management in the hospital, which can help inform treatment decisions and improve patient outcomes.

From the FDA Drug Label

1.1 Hypertension Lisinopril tablets USP are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Nicardipine injection is used to treat high blood pressure and control angina (chest pain) in certain patients.

  • Inpatient blood pressure medications include:
    • Lisinopril (PO) 2
    • Nicardipine (IV) 3 Key points:
    • Lisinopril is used to treat hypertension in adult and pediatric patients.
    • Nicardipine is used to treat hypertension and control angina in certain patients.

From the Research

Inpatient Blood Pressure Medications

The following medications are used to manage hypertension in the inpatient setting:

  • Nicardipine 4, 5, 6
  • Labetalol 5, 7, 4, 6
  • Hydralazine 7, 4
  • Nitroprusside 4
  • Fenoldopam 4
  • Nitroglycerin 4
  • Enalaprilat 4
  • Esmolol 4
  • Phentolamine 4
  • Clevidipine 4

Characteristics of Inpatient Blood Pressure Medications

These medications are often administered intravenously and are characterized by a short onset and offset of action, allowing for predictable responses during dosage adjustments to reach blood pressure goals 4. The selection of a specific agent should be based on the agent's pharmacology and patient-specific factors, such as comorbidity and the presence of end-organ damage 4.

Comparison of Inpatient Blood Pressure Medications

Studies have compared the effectiveness of different medications, such as nicardipine and labetalol, in managing hypertension in the inpatient setting 5, 6. These studies have found that nicardipine may be more effective than labetalol in achieving blood pressure targets, with fewer adverse effects 5. However, the choice of medication ultimately depends on individual patient characteristics and the specific clinical scenario 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous therapy for hypertensive emergencies, part 1.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.